Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients

Nuria Ribelles, José M. Jerez, Pablo Rodríguez-Brazzarola, Begoña Jiménez, Tamara Díaz-Redondo, Héctor Mesa, Antonia Márquez, Alfonso Sánchez‐Muñoz, Bella Pajares, F. Carabantes, María José Bermejo, Ester Martín-Villar, María Emilia Domínguez-Recio, E Sáez, Laura Gálvez, Ana Godoy-Ortíz, Leonardo Franco, Sofía Ruiz-Medina, Irene López, Emilio Alba